Biaryl substituted pyrazoles as sodium channel blockers

Details for Australian Patent Application No. 2004230854 (hide)

Owner Merck & Co., Inc.

Inventors Chakravarty, Prasun K.; Tyagarajan, Sriram; Parsons, William H.; Zhou, Bishan; Fisher, Michael H.

Agent Spruson & Ferguson

Pub. Number AU-A-2004230854

PCT Pub. Number WO2004/092140

Priority 60/460,106 03.04.03 US

Filing date 30 March 2004

Wipo publication date 28 October 2004

International Classifications

C07D 231/14 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/092140 Priority application(s): WO2004/092140

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230855-Razor blades having a non-linear cutting edge and a method for manufacture thereof

2004230844-Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof